Risankizumab Efficacy for Moderate-to-Severe Plaque Psoriasis over 256 Weeks in Patients with Prior Biologic Treatments
Authors: Jeffrey Crowley, Chih-Ho Hong, Melinda Gooderham, Georgios Kokolakis, Huzefa Photowala, Simone Rubant, Tianyu Zhan, Andrew Blauvelt
< PREVIOUS POSTER NEXT POSTER >
